Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study. | AHRQ Patient Safety Network

Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study. | AHRQ Patient Safety Network

• Study
 
• Published April 2018

Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study.

Gilbert RE, Kozak MC, Dobish RB, et al. J Oncol Pract. 2018 Apr 20; [Epub ahead of print].

This direction observation study identified multiple vulnerabilities in the chemotherapymedication compounding process. The authors emphasize the complexity of this entirely manual process and suggest that current practices carry significant risk for patient harm.

PubMed citationAvailable at

Related Resources

CASES & COMMENTARIES

Hyperbilirubinemia Refractory to Phototherapy

Vinod K. Bhutani, MD, and Ronald J. Wong

JOURNAL ARTICLE › REVIEW

Chemotherapy medication errors.

Weingart SN, Zhang L, Sweeney M, Hassett M. Lancet Oncol. 2018;19:e191-e199.

JOURNAL ARTICLE › COMMENTARY

Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system.

Chung C, Patel S, Lee R, et al. Am J Health Syst Pharm. 2018;75:398-406.

JOURNAL ARTICLE › STUDY

Oncology nurses' beliefs and attitudes towards the double-check of chemotherapy medications: a cross-sectional survey study.

Schwappach DLB, Taxis K, Pfeiffer Y. BMC Health Serv Res. 2018;18:123.

JOURNAL ARTICLE › COMMENTARY

Instituting vincristine minibag administration: an innovative strategy using simulation to enhance chemotherapy safety.

Corbitt N, Malick L, Nishioka J, Rigdon A, Szoch S, Torr P. J Infus Nurs. 2017;40:346-352.

View More